ClinicalTrials.Veeva

Menu

Bioequivalence of IMP 08P1902F0 Relative to Contramal® (100 mg/mL Oral Solution)

U

Unither Pharmaceuticals

Status and phase

Completed
Phase 1

Conditions

Healthy

Treatments

Drug: Tramadol Hydrochloride 100 MG/ML Oral Solution (Contramal(r))
Drug: Tramadol Hydrochloride 5 MG/ML Oral Solution

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05716763
UP-CLI-2021-001

Details and patient eligibility

About

This study aims to demonstrate the bioequivalence between the formulation of 5 mg/mL Tramadol Hydrochloride Oral Solution (08P1902F0) Relative to the reference product Contramal® (100 mg/mL Oral Solution).

Enrollment

24 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and non-pregnant female human subjects, age 18-50 years
  • Body mass index between 18.5-30 Kg/m²
  • Subject with normal findings
  • Willingness to follow the protocol requirements

Exclusion criteria

  • History of hypersensitivity to tramadol hydrochloride
  • Significant history of asthma, thyrotoxicosis, tumours, peptic or gastric ulcer, gastrointestinal malabsorption or haemorrhage in the gastro-intestinal tract, sinusitis, pharyngitis, renal disorder (impaired renal function), hepatic disorder (impaired hepatic function), cardiovascular disorder (ex. severe heart failure), neurological disease such as epilepsy, haematological disorders or diabetes, psychiatric, dermatologic or immunological disorders
  • Presence of any clinically significant results from laboratory tests,
  • lactating female or woman of childbearing potential unwilling to use an effective contraception

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

24 participants in 2 patient groups

Tramadol hydrochloride 5mg/mL oral solution (IMP 08P1902F0)
Experimental group
Treatment:
Drug: Tramadol Hydrochloride 5 MG/ML Oral Solution
Tramadol hydrochloride 100mg/mL oral solution (Contramal(r))
Active Comparator group
Treatment:
Drug: Tramadol Hydrochloride 100 MG/ML Oral Solution (Contramal(r))

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems